ARCHIMED is a global investment firm dedicated to making a positive impact in the healthcare industry. Through collaborations with scientists, healthcare professionals, entrepreneurs, and investors, ARCHIMED aims to support and improve healthcare companies. Their focus lies in areas such as internationalization, capacity increase, product range expansion, and acquisitions.

With a strategic emphasis on small-cap and mid-cap growth buyout transactions, ARCHIMED targets specific sectors within healthcare. Their approach includes integrating medical and operating expertise and utilizing a transatlantic platform to facilitate growth through internationalization. Through their diversified fund lines, ARCHIMED invests substantial amounts, ranging from 10 million to 1 billion euros, in leading healthcare companies.

Their MedSeg division is split into over 400 sub-sectors, allowing for individual assessments and prioritization of investment focus. ARCHIMED boasts a global team comprising more than 30 nationalities and over 140 team members. With offices across North America, Europe, APAC, and LATAM, they provide a wide-reaching network for their companies and investors.

ARCHIMED is committed to creating value at multiple levels. They strive to accelerate companies' growth rates by over 60% compared to pre-ARCHIMED performance. Their funds consistently deliver superior returns and adhere to strict sustainability standards.

Furthermore, ARCHIMED operates the EURÊKA Foundation, which supports community initiatives through financial contributions and volunteer work. Overall, ARCHIMED's comprehensive approach aims to foster sustainable and responsible growth within the healthcare industry